our Premium Content: News alerts, weekly reports and conference planners
GENE:
PRXL2B (Peroxiredoxin Like 2B)
i
Other names: PRXL2B, Peroxiredoxin Like 2B, Prostamide/Prostaglandin F Synthase, C1orf93, FAM213B, Thioredoxin-Type PGF Synthase, Prostamide/PG F Synthase, Prostamide/PGF Synthase, MGC26818, Family With Sequence Similarity 213, Member B, Family With Sequence Similarity 213 Member B, Chromosome 1 Open Reading Frame 93, Peroxiredoxin-Like 2B, Protein FAM213B
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
The predictive model of CMM related to lipid metabolism was constructed. TNFα activates the PLEKHA5-FCRLA axis to enhance neutral lipid storage and energy metabolism in CMM cells, promoting malignant behavior.
9 months ago
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • FCRLA (Fc Receptor Like A) • PRXL2B (Peroxiredoxin Like 2B)
In conclusion, we first report that oocyte vitrification did not significantly change the global gene expression in offspring organs; nonetheless, it can still influence the transcription of a few functional genes. The potential adverse effects caused by oocyte vitrification need attention and further study.
over 3 years ago
Journal
|
NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2) • TPM3 (Tropomyosin 3) • PRXL2B (Peroxiredoxin Like 2B)
These findings conclude the anti-TNBC mechanism of HRes should be attributed to its antioxidant activity and metformin enhances its reducibility. Metformin combined with resveratrol exerts a synergistic therapeutic effect on TNBC and effectively prevents tumor progression.